Literature DB >> 22451683

Tongue hyperpigmentation during hepatitis C treatment.

Claude Bachmeyer1, Jean-Charles Pellen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451683      PMCID: PMC3447020          DOI: 10.1503/cmaj.111985

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.

Authors:  Dina Farshidi; Melvin W Chiu
Journal:  J Am Acad Dermatol       Date:  2010-01       Impact factor: 11.527

2.  Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C.

Authors:  Calin Gurguta; Clemens Kauer; Ulrike Bergholz; Elisabeth Formann; Petra Steindl-Munda; Peter Ferenci
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

3.  Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.

Authors:  M Willems; K Munte; J M Vrolijk; J C Den Hollander; M Böhm; M H Kemmeren; R A De Man; J T Brouwer
Journal:  Br J Dermatol       Date:  2003-08       Impact factor: 9.302

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.